Congenital heart disease (CHD) refers to structural differences in the heart or nearby great vessels that are present at birth. CHD includes many different conditions, from mild lesions that may be monitored over time to critical forms that need urgent intervention.
Why CHD matters
CHD is among the most common categories of congenital anomalies globally. Outcomes have improved significantly because of advances in pediatric cardiology, surgery, catheter-based interventions, and long-term follow-up care.
However, delayed diagnosis and delayed referral can still increase complications, especially where access to specialist services varies.
What early pathways usually include
- Careful clinical assessment (history, growth, symptoms, physical exam).
- Screening tools where available (for example, pulse oximetry in newborn settings).
- Confirmatory imaging and specialist assessment, especially echocardiography.
- Follow-up plans tailored to the exact diagnosis and patient context.
CHD context in Indonesia
Indonesian pediatric literature and regional analyses commonly discuss CHD prevalence in the same broad range seen across many countries (often cited around 8–10 per 1,000 live births in published reports). Policy and hospital-based publications also highlight real challenges: uneven referral access, varying diagnostic capacity, and delayed diagnosis in some cohorts.
One Indonesian mixed-methods study in BMC Pediatrics reported a high proportion of delayed diagnosis in children with CHD in its study setting, underlining the importance of early recognition pathways and timely specialist referral.
How standardized heart-sound workflows can help
Standardized listening workflows complement clinical diagnosis by supporting:
- More consistent training and bedside practice habits.
- Cleaner, more comparable data capture for research and quality improvement.
- Better communication across teams using shared recording conventions.
This page supports education. For personal medical decisions, consult licensed clinicians.
References (trusted sources)
- Noormanto, et al. Delayed diagnosis in children with congenital heart disease: a mixed-method study. BMC Pediatrics. 2021. DOI: 10.1186/s12887-021-02667-3
- World Health Organization. Congenital disorders. WHO fact sheet
- Centers for Disease Control and Prevention (CDC). About Congenital Heart Defects. CDC CHD overview
- van der Linde D, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. Journal of the American College of Cardiology. 2011. DOI: 10.1016/j.jacc.2011.08.025
- Taksande A, et al. Global prevalence of congenital heart disease in neonates: a systematic review and meta-analysis. Frontiers in Pediatrics. 2023. DOI: 10.3389/fped.2023.1225512
Frequently asked questions
What is Congenital Heart Disease (CHD)?
Congenital heart disease (CHD) refers to structural differences in the heart or nearby great vessels that are present at birth. CHD includes many conditions, from mild lesions that may be monitored over time to critical forms that need urgent intervention.
What causes congenital heart disease?
Most CHD cases result from multifactorial influences during fetal heart development, including genetic factors, chromosomal conditions, and environmental or maternal health factors. In many children, a single definitive cause is not identified.
How is CHD diagnosed in children?
Diagnosis typically combines clinical assessment (history, growth, symptoms, physical exam), screening tools such as pulse oximetry where available, and confirmatory imaging—especially echocardiography—followed by specialist pediatric cardiology evaluation.
What is the treatment for CHD?
Treatment depends on the exact diagnosis and severity. Options range from monitoring mild lesions to medications, catheter-based interventions, surgery, and long-term follow-up care. Licensed clinicians determine the right pathway for each child.
What is the APTM listening protocol?
APTM is a fixed auscultation sequence: aortic, pulmonic, tricuspid, then mitral. StetoRadr uses this order so heart-sound recordings stay comparable across listeners and sites for training and research—not as a diagnostic device.
Interested in StetoRadr?
StetoRadr supports standardized APTM heart-sound capture for research and care teams. Request updates or pilot information.
Request information →